Company Information
Industry 制造业
Company Introduction 致力于以高科技手段实现珍稀自然资源的合理开发与可持续发展,在创新理论指导下实现传统产业的价值创新,青海春天(股票代码:600381)聚焦于酒水和大健康产业板块,为消费者提供品质卓越、更有价值的产品。 公司旗下的听花酒系列产品,在“双激活”健康酿酒理论指导下,运用定向菌和特制香曲二次发酵、精馏浓缩等减害增益新工艺,对醇熟老酒再酿造,实现酒体价值飞跃:风味口感升级和饮后价值的创新。 在大健康产业板块,青海春天在对冬虫夏草开展系统研究的基础上,结合现代药物的制剂工艺与技术,于2009年正式推出了极草5X系列冬虫夏草纯粉产品,该系列产品作为冬虫夏草物理加工领域的最高科技成果,为冬虫夏草整个产业带来划时代的变革。公司目前已完成了涵盖保健食品、药品等冬虫夏草高效利用产品的储备和战略布局,拥有六个以冬虫夏草为主要原料的中药产品和储备有六种同样以冬虫夏草为主要原料的保健食品的产品。 公司创立了由全球顶级科学家、博士生导师、博士、硕士等高级工程技术人员组成的研发平台。1998年“诺贝尔生理学或医学奖”获得者斐里德·穆拉德、2013年“诺贝尔化学奖”获得者亚利耶·瓦谢尔与青海春天董事长张雪峰为公司联席首席科学家,致力于将诺奖成果用于酒类产品研发,追求更优质的口感风味,促进白酒健康化发展,引领世界蒸馏酒健康化航向的新未来。 青海春天一直坚持“通过创新研究,持续为消费者提供优质、安全和健康的产品”的发展愿景和理念,坚守持之以恒、永不放弃的人文精神,攻坚克难、使命必达的创新精神,为消费者创造价值的人本关怀精神,以更有价值的产品传递关爱,用智慧开创人与自然的和谐。
Main Business 一是以酒水产品销售为主的酒水快消品业务板块,二是以冬虫夏草类产品研发、生产和销售为主的大健康业务板块。
Legal Representative 张雪峰
Top Executives
董事长:张雪峰
董事:陈定,姚铁鹏
独立董事:高学敏,董博俊,王富贵
Top 5 Shareholder
Shareholder name Nature Holding Date
西藏荣恩科技有限公司流通A股32.13%30/09/2026
肖融流通A股9.67%30/09/2026
青海春天药用资源科技股份有限公司回购专用证券账户流通A股2.50%30/09/2026
胡振民流通A股1.29%30/09/2026
朱秋连流通A股1.09%30/09/2026
Company Secretary 付晓鹏
Solicitors 北京市君泽君律师事务所
Auditors 北京兴华会计师事务所(特殊普通合伙);瑞华会计师事务所(特殊普通合伙)
Tel No 0971-8816171
Fax No 0971-8816171
Website www.verygrass.com
Email investor@verygrass.com
Company Address
Register: 青海省西宁市城北区生物园区经二路12号
Office: 青海省西宁市城北区生物园区经二路12号五楼
Listing Date 08/05/2001
Shares Capital
Shares Capital: 587,060,741
Total A Share: 587,060,741
Listed A Share: 587,060,741
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.070
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 1.695
Market Capitalization(RMB) 2.049B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.